在外源性脂质肺炎的环境中进行全肺洗
Gaurav A Jategaonkar1, John Fanous2, Ryan Dunn3
1Mayo Clinic Alix School of Medicine, United States.
Respiratory medicine case reports
|August 4, 2025
概括
全肺洗有效地治疗了对类固醇耐药的外源性脂质肺炎病例,这种疾病是由吸入或摄入脂质引起的. 这种程序为严重的病例提供了一个有希望的替代方案,这些病例对标准疗法没有反应.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 毒理学 毒理学 毒理学
背景情况:
- 外源性脂质性肺炎 (ELP) 是由于吸入或吸入物质 (通常是矿物油) 的肺脂沉积引起的.
- 标准的ELP治疗包括去除侵扰剂和皮质类固醇,但对于耐固醇病例的选择有限.
研究的目的:
- 报告使用全肺洗成功治疗类固醇耐药的外源性脂质肺炎.
- 突出整肺洗作为一种可行的选择,用于严重的ELP病例,对皮质类固醇无反应.
主要方法:
- 一名56岁的男性患有耐火性外源性脂质性肺炎,通过活检确认并以脂质负载的巨细胞为特征,接受了治疗.
- 患者在左肺进行了整体肺洗.
- 在术后监测临床和成像结果.
主要成果:
- 患者在全肺洗后的第二天经历了成功的输出管,并在四天后出院.
- 治疗有效地控制了症状,并改善了耐固醇ELP的状况.
- 支气管支气管洗显示高百分比 (59%) 的脂质负载的巨细胞,表明显著的脂质积累.
结论:
- 全肺洗在严重的类固醇耐药外源性脂质肺炎的情况下显示出显著的疗效.
- 这种手术对耐火ELP患者来说是一个有前途的治疗途径.
- 这些发现支持全肺洗在管理复杂呼吸道疾病中的作用不断扩大.
相关概念视频
Transmission-based Precautions II: Airborne and Protective Environment
2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Pulmonary Tuberculosis V
1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Acute Respiratory Failure-V
768
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24


